Natural Grocers by Vitamin Cottage, Inc. (NGVC)

NYSEConsumer StaplesGrocery StoresSnapshot 2026-10-23

$31.46-2.81%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Natural Grocers by Vitamin Cottage, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	349.93M
EPS	—	0.533
Annual ending 2027-09-30
Revenue	—	1.44B
EPS	—	2.266
Annual ending 2028-09-30
Revenue	—	1.39B
EPS	—	2.13

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
CAPEX between $45M and $50M	A supporting condition in Natural Grocers by Vitamin Cottage, Inc.'s published investment case. The stated target is CAPEX $45M-$50M.	Intact	CAPEX exceeds $55M or falls below $40M	Capital expenditures: $9.554M FY2026-Q3; GAAP. Published target: CAPEX $45M-$50M. Target period is not explicitly aligned with this observation. Source published Aug 6, 20269,554,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS >= $2.12 next fiscal year	Profit per share should reach about $2.12 next year.	Broken	EPS falls below $2.00 in FY 2026	Diluted EPS: $0.48 per share FY2026-Q3; GAAP. Published target: >= $2.12 per share. Target period is not explicitly aligned with this observation. Source published Aug 6, 20260.48 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 9e0ec452-d9be-4012-a34e-e1481fa81d1c. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
annual revenue growth >=7.5%	A primary condition in Natural Grocers by Vitamin Cottage, Inc.'s published investment case. The stated target is >=7.5% YoY.	Broken	YoY revenue growth falls below 7% next year	Revenue growth: 1.84% FY2026-Q3; GAAP. Published target: >=7.5% YoY. Target period is not explicitly aligned with this observation. Source published Aug 6, 20261.835689 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 9e0ec452-d9be-4012-a34e-e1481fa81d1c. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
PE ratio near or below 17.5x	It has a cheap valuation with a price-to-earnings ratio below peers.	Intact	PE rises above 20x without earnings growth	P/E (TTM): 15.27x As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 202615.2718 ratio · calculatedLast status assessment Oct 24, 2026 Measurement source consolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: NGVC:2026-10-23. Source status: canonical calculation. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-30 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-01	Unavailable	Unavailable	1 / 1
2026-10-02	Unavailable	Unavailable	1 / 1
2026-10-03	Unavailable	Unavailable	1 / 1
2026-10-04	Unavailable	Unavailable	1 / 1
2026-10-05	Unavailable	Unavailable	1 / 1
2026-10-06	Unavailable	Unavailable	1 / 1
2026-10-07	Unavailable	Unavailable	1 / 1
2026-10-08	Unavailable	Unavailable	1 / 1
2026-10-09	Unavailable	Unavailable	1 / 1
2026-10-10	Unavailable	Unavailable	1 / 1
2026-10-11	Unavailable	Unavailable	1 / 1
2026-10-12	Unavailable	Unavailable	1 / 1
2026-10-13	Unavailable	Unavailable	1 / 1
2026-10-14	Unavailable	Unavailable	1 / 1
2026-10-15	Unavailable	Unavailable	1 / 1
2026-10-16	Unavailable	Unavailable	1 / 1
2026-10-17	Unavailable	Unavailable	1 / 1
2026-10-18	Unavailable	Unavailable	1 / 1
2026-10-19	Unavailable	Unavailable	1 / 1
2026-10-20	Unavailable	Unavailable	1 / 1
2026-10-21	Unavailable	Unavailable	1 / 1
2026-10-22	Unavailable	Unavailable	1 / 1
2026-10-23	Unavailable	Unavailable	1 / 1
2026-10-24	Unavailable	Unavailable	1 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	3	0	0
2026-06-01	3	0	0
2026-07-01	3	0	0
2026-08-01	3	0	0
2026-09-01	4	0	0
2026-10-01	4	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

CAPEX between $45M and $50MCapital expenditures: $9.554M
EPS >= $2.12 next fiscal yearPublished status: Broken
annual revenue growth >=7.5%Published status: Broken
PE ratio near or below 17.5xP/E (TTM): 15.27x

Next proof point

Nov 19, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.5%Typical daily move · historical

Downside history

-41.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Natural Grocers by Vitamin Cottage, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

NGVC is a smaller-cap grocery business with a store-growth thesis, rather than a clear turnaround. Its long-term thesis is intact, supported by robust earnings quality and stable management, while recent financial performance is neutral and risk is elevated.

What's priced into Natural Grocers by Vitamin Cottage, Inc.

The valuation is described as cheap versus peers, and it has fallen substantially in the recent period. The evidence labels the expectations gap as small and pricing as justified, with low fragility; it does not show that the market is assuming a sharp change in the business.

What the fundamentals likely do

Near term, store expansion is on track: management has opened six stores fiscal year-to-date and refined its 2026 goal to six to seven. Comparable-store sales improved to 1.2% in Q3 from 0.5% in Q2, but management lowered its growth outlook, and recent results include an August earnings miss. Spending appears disciplined, though the next guidance update and weaker employment conditions are risks.

What Natural Grocers by Vitamin Cottage, Inc. hinges on

The multi-year view depends on NGVC delivering planned store growth while improving comparable-store sales without further guidance cuts. Near term, weaker employment or reduced guidance could weigh on the business outlook, while continued strong results and guidance from grocery peers would support sector momentum.

Bottom line

Over the next 1 to 3 years, the thesis rests on steady store expansion and better sales execution, with a cheap-versus-peers valuation offset by elevated risks and mixed recent performance. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.